A phase II study of maintenance rucaparib in patients with platinum sensitive, advanced pancreatic cancer and a pathogenic germline or somatic variant in BRCA1, BRCA2 or PALB2: A four year survival update.
Authors:
- 20 January 2024
- journal article
- abstracts
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 42 (3_suppl) , 661
Abstract
No abstract availableKeywords
Funding Information
- Clovis Oncology
- Basser Center for BRCA.